- Conditions
- Refractory Childhood Epilepsy
- Interventions
- cannabidiol (CBD)
- Drug
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 1 Year to 17 Years
- U.S. locations
- 1
- States / cities
- Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Jan 21, 2026 · Synced May 22, 2026, 3:47 AM EDT